Le Lézard
Classified in: Health
Subject: NPT

Bright Now!® Dental in Kennewick, WA to Host a Free Dental Clinic


KENNEWICK, Wash., Feb. 16, 2020 /PRNewswire-PRWeb/ -- In Partnership with the Smiles for Everyone Foundation, Bright Now!® Dental will provide free dental services at its Kennewick, WA office.

A limited number of appointments are available, but there is plenty of room for walk-ins if individuals are unable to schedule beforehand. For more information or to schedule an appointment, please call (509)-820-4302.

Who: Bright Now! Dental
Where: 1220 N. Columbia Center Blvd Suite A105, Kennewick, WA 99336
When: Saturday, March 28th, from 8:30am to 2:00pm.

Dental services provided include same-day procedures such as exams and x-rays, fillings, cleanings and extractions. To be eligible to receive care, individuals must be low-income or underinsured.

About Bright Now!® Dental
Bright Now! ® Dental provides general dentistry, children's dentistry and, in select locations, specialty care services such as orthodontics, oral surgery, periodontics and endodontics at over 150 offices across Arizona, California, Colorado, Florida, Indiana, Maryland, Ohio, Oregon, Pennsylvania, Utah, Virginia and Washington. Bright Now! Dental's Kennewick office is operated by Nurani, P.C. (the "Group"). The Group is affiliated with Smile Brands Inc., one of the largest providers of business support services to dental groups in the United States. Smile Brands Inc. provides comprehensive business support services through exclusive long-term service agreements with affiliated dental groups, so dentists can spend more time caring for their patients and less time on the administrative, marketing and financial aspects of operating a dental practice. Smile Brands is a portfolio company of Gryphon Investors ("Gryphon"), a leading middle-market private equity firm based in San Francisco, CA. For more information, visit http://www.smilebrands.com.

About the Smiles For Everyone Foundation
The Smiles for Everyone Foundation is a 501(c)(3) nonprofit organization with the mission of delivering smiles for everyone by providing free dental care for those in need, both at home in the U.S. and around the world. Since 2011, the Smiles for Everyone Foundation has delivered over 26,000 smiles and over $19 million in donated dentistry. The foundation currently supports programs which provide free dental care to those in need in Cambodia, Ghana, Laos, Nicaragua, Paraguay, Thailand, and the United States. For more information or to make a donation, visit http://www.smilesforeveryone.org.

Contacts:
Bright Now!® Dental                    
Jody Martin    
PR@smilebrands.com                            
714.427.1299                    

Smiles for Everyone Foundation
Crystal Strait
crystal.strait@smilesforeveryone.org
714.824.5037

 

SOURCE Bright Now!® Dental


These press releases may also interest you

at 07:10
The Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial for FARXIGA (dapagliflozin) in patients with chronic kidney disease (CKD) will be stopped early following a recommendation from an independent...

at 07:10
IMV Inc. , a clinical-stage biopharmaceutical company (the "Company" or "IMV"), today provided updates on the development of DPX-COVID-19, a vaccine candidate against the novel coronavirus, and on the Company's business and clinical operations amid...

at 07:05
LifeMax Laboratories, Inc. ("LifeMax"), a private company focused on treating orphan diseases that have few or no therapeutic options, today announced the formation of AmMax Bio, Inc. ("AmMax") and an exclusive worldwide license from Amgen for the...

at 07:05
AstraZeneca today announced that IMFINZI® (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SoC) chemotherapies, etoposide...

at 07:05
ElevateBio, LLC, a Cambridge-based creator and operator of a portfolio of innovative cell and gene therapy companies, today announced it has closed a $170-million Series B financing that will support and accelerate the company's next phase of growth....

at 07:05
Generation Bio and Vir Biotechnology today announced a collaborative research agreement to explore the potential for Generation Bio's non-viral gene therapy platform to extend the impact and reach of Vir's current or future human monoclonal...



News published on 16 february 2020 at 08:00 and distributed by: